Skip to main content

CVE detail

CVE-2026-20162

In Splunk Enterprise versions below 10.2.0, 10.0.3, 9.4.9, and 9.3.9, and Splunk Cloud Platform versions below 10.2.2510.4, 10.1.2507.15, 10.0.2503.11, and 9.3.2411.123, a low-privileged user who does not hold the "admin" or "power" Splunk roles could craft a malicious payload when creating a View (Settings - User Interface - Views) at the `/manager/launcher/data/ui/views/_new` endpoint leading to a Stored Cross-Site Scripting (XSS) through a path traversal vulnerability. This could result in execution of unauthorized JavaScript code in the browser of a user. The vulnerability requires the attacker to phish the victim by tricking them into initiating a request within their browser. The authenticated user should not be able to exploit the vulnerability at will.

CVSS 6.3 · MediumBuzz score 11.9

Buzz score

Why this CVE is surfacing

Buzz score total 11.9

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 6.9 · diversity 5.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
6.9
1 evidence mentions in the snapshot
Diversity score
5.0
1 sources across 1 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
0
within the 30d window
Peak daily
0
highest bucket

Evidence

Source links by recency

Newest mentions first
1 source links · newest first

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence